The Future of Personalized Medicine

Add to your list(s) Download to your calendar using vCal

• Stefan Harrer - IBM Research
• Tuesday 23 September 2014, 14:00-15:00
• Kapitza Building, MRC Seminar Room, Cavendish Laboratory, Department of Physics.

If you have a question about this talk, please contact Jerome Charmet.

Everyone is welcome

DNA -sequencing approaches the 1000-Dollar-Genome milestone allowing for decoding a complete human genome with unmatched speed and at low cost. Increased sequencing efficiency yields massive amounts of genomic data. Analysis of this data eventually enables understanding the role of each DNA segment and its correlation with the risk of developing a certain disease. New drug targets are identified and validated continuously and can be matched with a personalized genetic risk assessment. Access to this information triggers fundamental questions for doctors and patients alike: What are the chances of an outbreak? Are drugs available? What is the best combination of prevention and treatment? In order to provide answers, technologies for discovering novel drugs, for improving existing drugs and for their intelligent use in an increasingly complex environment, will have to be revolutionized. The path from fast and cheap personalized sequencing via genomics big data analysis towards personal prevention and treatment will reshape medicine as we know it. IBM Research works at the forefront of this process: we develop bionanosensor chips for next-generation DNA -sequencing and drug discovery, and we employ supercomputers for life sciences research, genomics analysis and smarter healthcare. We strive to re-invent personalized medicine, the next big thing emerging from marrying nanotechnology, biotechnology and the power of big data. In this talk I will describe IBM ’s engagement in biospace research with a special focus on two of our bionanotechnology flagship projects: (I) IBM ’s “DNA Transistor”, a 4 th -generation nanopore-based DNA -sequencing chip, and (II) the Bionanotechnology Research Program” of IBM Research Australia which aims at developing novel ways for drug discovery and screening.

This talk is part of the Nanoscience Centre Seminar Series series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• Cambridge Infectious Diseases
• Chris Davis' list
• Dobson Group - General Interest
• Featured talks
• Guy Emerson's list
• Kapitza Building, MRC Seminar Room, Cavendish Laboratory, Department of Physics
• Nanoscience Centre Seminar Series
• Pathology Seminars
• School of Physical Sciences
• School of Technology
• custom

Note that ex-directory lists are not shown.